Keep up to date with every new upload!

Join free & follow Rheumatology, Oxford Journals
  • 9 years ago
Cost of using TNF-alpha inhibitors - (April 2010)

Cost of using TNF-alpha inhibitors - (April 2010)

What is the cost–utility of different treatment strategies after the failure of tumour necrosis factor inhibitor in rheumatoid arthritis?. This paper, set in Finland, by Hallinen et al. is discussed by Professor Robert Moots and Dr. Ronald Frits van Vollenhoven. In the Podcast, they discuss current use of biologics, the effectiveness of TNF inhibitors, DMARDs and rituximab and consider whether the economic model used in this paper can effectively determine relative cost-effectiveness in a clinical setting.